Background: Tuberculosis is a global health problem and emergence of MDR TB is a major threat to tuberculosis care and control. Treatment of MDR TB is challenging due to toxicity of second-line drugs used. Elderly population has several risk factors that can increase their susceptibility to ADR. Methods: A retrospective analysis of records of MDR TB patients admitted, to Group of T.B. Hospital, a specialized TB hospital in Mumbai, India, during January 2016 -December 2016, was carried out to evaluate ADRs in patients ≥ 60 years of age and compare it with patients < 60 years. ADRs were assessed for system organ classification, seriousness, severity causality, related suspected drugs, preventability using standard methods, and for possible risk factors. Results: Out of 732 patients admitted, 33 were ≥ 60 years, 99 (three times) patients < 60 years were randomly identified from the remaining 699 of which 91 with required records were included in the analysis. Patients ≥ 60 years had significantly greater incidence of ADRs compared to<60 years age group. ADRs like vomiting, giddiness, otovestibular toxicity (tinnitus and vertigo) and hearing loss were significantly more in patient ≥ 60 years. Patients ≥ 60 years and with diabetes mellitus had significantly more ADRs as compared to patients < 60 years and with DM. ADRs were found to be possibly preventable by proper preventive measures and management as per guidelines. Conclusion: Elderly population is increasing worldwide and is vulnerable to more ADRs due to comorbidities, pharmacokinetic, pharmacodynamics changes and social factors. Recognition of this vulnerability, emphasis on careful history, counselling and monitoring will help prevent ADRs and better manage elderly DR TB patients.
Introduction
Tuberculosis is a global public health problem, and is one of the top ten causes of death worldwide and has caused more deaths than HIV in 2015 1 . India has the largest number of TB patients with an estimated incidence of 2.8 million cases of TB out of a global incidence of 10.4 million. Despite extensive tuberculosis control efforts on the part of World Health Organization (WHO) and local health departments, the tuberculosis epidemic continues to ravage the developing world, affecting all susceptible individuals, including the aging adults 2 .
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The emergence of multi drug resistant tuberculosis (MDR TB) is a major threat to global tuberculosis care and control. MDR TB is defined as resistance to isoniazid and rifampicin with or without resistance to other anti TB drugs. It takes longer to treat MDR TB and itis associated with higher mortality 3 . Treatment of MDR TB is challenging due to toxicity to second line drugs 4 . Adverse drug reactions are a major cause of hospital admissions mortality, morbidity and increased health care costs in the treatment of MDR TB. Studies have shown that the risk factors associated with adverse reactions to antituberculosis drugs are: gender, race/ethnicity, nationality, age, weight, marital status, treatment regimen, genetic factors, anemia, co-infection with HIV, HBV, or HCV, diabetes, liver disease, hypoalbuminemia, hyponatremia, lymphopenia, and alcohol, tobacco, or illicit drug use 5 .. Age is a very important factor which affects the occurrence of ADRs 6 .Population over 60 is increasing rapidly and related health care issues have been focus of attention. The International Conference on Harmonization considers older people a 'special population', as they differ from younger adults in terms of comorbidity, polypharmacy, pharmacokinetics and greater vulnerability to adverse drug reactions 7 . Although, ADRs to first line to antitubercular drugs in elderly patients have been reported, there are only a few reports on ADRs to MDR TB drugs in elderly. While reporting and analysis of ADRs is important, assessing preventability and guidelines for preventing ADRs is crucial. The present study was carried out to evaluate ADRsdue to antitubercular drug in MDRTB patients ≥ 60 years of age, focusing on risk factors and preventability.
Methods
This is a retrospective study of records of MDRTB patients admitted to GTB hospital during January 2016-Dec 2016 Period. GTB hospital is a 1200 bedded specialized TB hospital located in Mumbai in India, 200 beds are reserved for drug resistant patients. Patients are admitted for disease related complication or any adverse drug reaction. Indoor records of patients admitted during 1stJanuary 2016 to 31 st December 2016 period were screened for patients of more than or equal to 60 years of age . Thirty three patients were found to be≥ 60 years of age. Out of remaining 699 patients <60 years of age, 99 patients i.e. three times the number of older patients, were randomly selected for the comparative group. Complete information was available for 91 of these 99 patients and their records were used for the comparative analysis. Patients who were not admitted during1 st January to 31 st December 2016 period were excluded. Patient information ondemography, signs and symptoms, treatment regimen and investigations was extracted from the hospital records of the hospital admitted patients. W.H.O defines adverse drug reaction (ADR) as "Any response to a drug which is noxious, unintended and occurs at doses used in man for prophylaxis, diagnosis or therapy." ADRs were identified from the case history, clinical examination and investigations and were considered serious if recorded as cause for admission. ADRs were classified according to the system organ classification of the WHO. ADRs were assessed for causality using WHO criteria as certain, probable, possible, unlikely, unclassifiable and for preventability using Schumoch and Thornton criteria as definitely preventable, possibility preventable, not preventable, unevaluable The data was entered in the MS Excel sheet and statistical analysis was carried out using SPSS software version 16. Descriptive statistics (mean and standard deviation) were done for quantitative parameters and various parameters were compared using chi square method. Permission to access patient data was obtained from the Medical Superintendent of TB Hospital. Ethics committee permission was not deemed necessary as it was retrospective analysis of patient records and part of routine activity of the hospital.
Results
The screening of records of patients admitted during 1 st from January 2016 to 31 st December 2016 period showed that 732 patients were admitted to DRTB ward. Data of 33 patients ≥60 years and 91 patients of <60 years of age (whose records were complete) were extracted, compiled and analyzed. The mean age of patients in the age group <60 years was found to be 30.84+-12.06 years and in the age group≥ 60 years it was 63.60 +/-3.28 years. This hospital does not have facilities for managing extra pulmonary TB. Thus most cases (122) were with pulmonary TB, only two had extra-pulmonary TB. All cases were of Drug resistant TB however whether it was primary or secondary resistance could not be evaluated as that data was not entered in the records for most (except 5 cases). 104 cases were receiving conventional MDR TB regimen, 78 were on intensive phase (6-9 months) and 26 were in continuation phase, (18 months). Twenty patients were on treatment regimen for XDR patients, of which 16 were in intensive phase (6-12 months) and four were in continuation phase (18 months) The analysis showed that the ADRs were present in 63.63% of older age group, as compared to 29.67% of younger age group (P value of <0.05). Issues related to elderly population have been recently reviewed and are of concern 12 . Gerontologists define elderly as young old (65-74), middle old (75-84) and very old (>85). The cut off age for elderly in India is 60 years. The population over 60 is rapidly increasing in the world's most populist countries. In India, 5% of the population wasover 60 in 1950 and 7.3% in 2000; the proportion is projected to be 19% in 2050; in China, comparative figures are 7.7%, 10% and 32%. The number of elderly people in India is projected to reach 158.7 million in 2025 and by 2050, to surpass the population of children below the age of 14 years. Globally the elderly population (aged >=60 years) is expected to increase to more than 2 billion in 2050. The prevalence of non-communicable diseases and the morbidity due to re-emerging infectious diseases is high in older people, and varies across gender, area of residence, and socioeconomic status. According to National Sample Survey Office India data, 28.3% of older people in rural and 36.8% in urban areas, suffer from one or more diseases. About 106 out of every 1000 suffer from heart diseases and 55 of 1000 in urban area have some sort of disability such as poor vision, hearing difficulty or locomotive impairment. According to the non-governmental organization help age 2014 report, more than a quarter of existing 100 million Indian older people are under weight and nearly 1/3 has undiagnosed hypertension. Furthermore, about 1 old individual in 5 is depressed. 2/3 of the elderly population lives in villages, half are of poor socio-economic status and of this, 70% are women, all of which further jeopardizes their health status and access to care. Although person aged over 65 years represent about 13% of the population, they consume 1/3 of all medicines. Over prescribing is a serious concern. Older patients often consult several doctors who may be unaware of prior consultations, add more drugs, and thereby complicate matter further. On the other hand, under prescribing of appropriate medications is also of concern. Studies of drug effectiveness often exclude the older population whereby the benefit risk ratio is not known. The pharmacokinetic and pharmacodynamic properties of drugs change as adults grow older, for e.g. older patients have an increased volume of distribution for lipid soluble drugs as the proportion of fat to lean body mass increases with age. Renal function declines, increasing concentration of renally excreted drugs like aminoglycosides. Sensitivity to centrally acting drugs like benzodiazepines increases. Formulations packaging and package inserts are unmindful of the needs of older people, the elderly may have mechanical difficulties making it hard to break tablets by hand or open medicine packs, visual difficulties making it hard to read packages labeling, and swallowing problems that necessitates liquid preparations. All these factors limit access to beneficial drug therapy, reduce compliance, and increase adverse drug reactions. Several
European and International recommendations have been made regarding the development, formulation, and drug product design for the elderly. The ICH Q8 guideline "Pharmaceutical development". European Medicines Agency (EMA) good practice guide on risk minimization and prevention of medication errors, and EMA committee on Human medicinal product. QWP (Quality Working Party) reflection paper, all consider aspects of medicines for older people. Indian drug regulations requires prescribing information ( in packaging insert) on the use of drugs in special population including geriatrics. But there is no provision to design package or label specifically keeping in mind the needs of the elderly. Schedule Y of Drugs And Cosmetics Act (DCA) of India stipulates that older subject should be included in meaningful numbers in phase 2 and phase 3 trials at the sponsor's option., if the diseases affect elderly people. There is no specific requirement in Indian Law that requires reporting of clinical trials result to be disaggregated by age.
Results of our study show significantly higher ADRs in elderly compared in<60 years age group. Patients with diabetes had significantly higher ADRs. Patients ≥ 60 age had significantly more vomiting, giddiness, hearing loss, tinnitus and vertigo. ADRs were assessed as possibly preventable with proper selection of drug dose, emphasis on proper history, early diagnosis and proper management. Elderly patients may have existing dizziness, low hearing, and depression. ICMR and Central TB Control division have developed manual and Ready Reckoner for general practitioners for prevention and management of ADRs to antitubercular drugs. Ready Reckoner provides in a tabular format details of ADRs, suspect drugs, differential diagnosis, prevention and management 13 . ADRs can be prevented for e.g. by taking anti TB drugs with food to prevent vomiting. For psychosis, careful monitoring and psychiatric counseling at the start of treatment in patients at risk, for Oto toxicity and hearing loss, monitoring of early symptom, can prevent worsening and permanent ear damage. Regular ophthalmologic examination can be done to prevent blurring of vision or blindness. There is need to recognize that elderly population is increasing, will form a proportion of TB cases and will need special attention due to their vulnerability.
Conclusion
MDR TB drugs could cause significantly more adverse drugs reaction in the elderly due to various age related risk factors such as concomitant diseases, altered pharmacokinetic and pharmacodynamics and use of multiple drugs. The results of our study suggest that the protocol of anti-TB therapy and management of ADRs in older patients needs to be specially emphasized and may need some revision to prevent known ADRs.
Limitation
The current study was retrospective analysis of patient records and information regarding ADRs, concomitant diseases and other risk factors may be incomplete. renal failure, the effect of drugs on the kidneys is lessened because of the loss of the site of action for these drugs. This leads to increasing the dose which in turn leads to more ADRs 20 . One of the common ADRs in MDR TB treatment is hepatotoxicity. One of the studies showed that being less than 65 years of age is a protective factor for hepatitis, whereas another showed that being ≤ 60 years of age is a protective factor for drug-induced hepatotoxicity. Other common ADRs include arthralgia, exanthema, and unspecified reactions (kidney disorders, jaundice, hearing loss, liver problems, and skin rash). Another study showed that age (< 60 years) was a significant protective factor for unspecified reactions. According to two studies, elderly patients (over 60 or 65 years of age) are more likely to have ADRs due to the fact that elderly individuals have a slower metabolism, which is due to reduced enzymatic activity, reduced hepatic clearance, and reduced availability of essential endogenous cofactors 5 . The present study aimed at assessing ADRs and co-morbid conditions among elderly population suffering from MDR tuberculosis in an attempt to improve identification of ADRs in elderly patients and formulate prevention strategies targeting the prescribing and monitoring stages of pharmaceutical care because drugs are less likely to be studied extensively in extremes of age, and drug absorption and metabolism are more variable and less predictable in this age group. Efforts are needed to predict and prevent the occurrence of ADRs in older population. The study also aimed at comparing these parameters with non-elderly population. Also, male preponderance was observed in the present study (males 58.87% and females 33.06%), other studies 4, 10 from India have shown similar findings. Dheeraj Gupta's study from Northern India showed male preponderance of 66% while Kapadia VK's study from Ahmedabad reported 63.49% males and 36.51% female patients with ADRs. Malnourishment was seen in 54% of the patients having ADRs in the present study. Flora S Nyakistudy 11 from Tanzania reported 53% MDR patients suffering from malnourishment, similarly a study by Sachin Atre 12 from Mumbai, India reported a high percentage (75%) of malnourishment among MDR TB patients. These findings are in consistent with the findings of our study where a high proportion of patients were found to be malnourished. Malnourishment is a major risk factor for ADRs and thus, should be taken into account while managing TB patients. Of the total patients, 67% of the patients were suffering from diabetes and had at least ADR. One of the studies showed similar findings where diabetes mellitus was seen in 25.8% patients and 70% of those patients had with diabetes 12 . Another study 13 from central India showed that the incidence of ADR was more in patients with diabetes (80%) than those without diabetes (47%). Therefore, patients with concomitant diseases are more likely to have ADRs and should be treated and managed appropriately. The ADRs ranged from 57.14% to 69.2% in MDR TB patients in a number of studies 4, 13, 14, and 15 which is consistent with the findings of our study. It is known that not all patients develop the same level and type of ADRs. Age is a very important factor which affects the occurrence of ADRs. Elderly patients with multiple medical problems who are taking multiple drugs, those who have a history of ADRs, and those with a reduced capacity to eliminate drugs are at high risk for ADRs. Practice guidelines are often drawn from the results of clinical trials from which frail, older and comorbid people have been excluded. The extrapolation of evidence from younger, healthier and physiologically different populations to older people make it difficult to predict reliably the prevalence and nature of adverse drug events that can be expected in 'real world' usage. The main contributors to altered pharmacokinetics are age related changes in organ mass and blood circulation along with changes in body composition. Thus, it can be concluded that ADRs observed more among elderly TB patients make it important to consider concomitant diseases, age, and other risk factors while treating and managing TB especially MDR TB patients. Some easily manageable ADRs like vomiting associated with MDR treatment can be minimized by administering antiemetics as well as consuming tablets along with food. All MDR patients should undergo screening for immuno-compromised state and if diagnosed, strict management of the same is essential.
